142 related articles for article (PubMed ID: 26558469)
1. S-Mercuration of ubiquitin carboxyl-terminal hydrolase L1 through Cys152 by methylmercury causes inhibition of its catalytic activity and reduction of monoubiquitin levels in SH-SY5Y cells.
Toyama T; Abiko Y; Katayama Y; Kaji T; Kumagai Y
J Toxicol Sci; 2015 Dec; 40(6):887-93. PubMed ID: 26558469
[TBL] [Abstract][Full Text] [Related]
2. Glutathione-mediated reversibility of covalent modification of ubiquitin carboxyl-terminal hydrolase L1 by 1,2-naphthoquinone through Cys152, but not Lys4.
Toyama T; Shinkai Y; Yazawa A; Kakehashi H; Kaji T; Kumagai Y
Chem Biol Interact; 2014 May; 214():41-8. PubMed ID: 24582816
[TBL] [Abstract][Full Text] [Related]
3. Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.
Contu VR; Kotake Y; Toyama T; Okuda K; Miyara M; Sakamoto S; Samizo S; Sanoh S; Kumagai Y; Ohta S
J Neurochem; 2014 Sep; 130(6):826-38. PubMed ID: 24832624
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron.
Osaka H; Wang YL; Takada K; Takizawa S; Setsuie R; Li H; Sato Y; Nishikawa K; Sun YJ; Sakurai M; Harada T; Hara Y; Kimura I; Chiba S; Namikawa K; Kiyama H; Noda M; Aoki S; Wada K
Hum Mol Genet; 2003 Aug; 12(16):1945-58. PubMed ID: 12913066
[TBL] [Abstract][Full Text] [Related]
5. Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1.
Meray RK; Lansbury PT
J Biol Chem; 2007 Apr; 282(14):10567-75. PubMed ID: 17259170
[TBL] [Abstract][Full Text] [Related]
6. Glutathione adduct of methylmercury activates the Keap1-Nrf2 pathway in SH-SY5Y cells.
Yoshida E; Abiko Y; Kumagai Y
Chem Res Toxicol; 2014 Oct; 27(10):1780-6. PubMed ID: 25271560
[TBL] [Abstract][Full Text] [Related]
7. Correlation between attenuation of protein disulfide isomerase activity through S-mercuration and neurotoxicity induced by methylmercury.
Makino K; Okuda K; Sugino E; Nishiya T; Toyama T; Iwawaki T; Fujimura M; Kumagai Y; Uehara T
Neurotox Res; 2015 Feb; 27(2):99-105. PubMed ID: 25288108
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin C-terminal hydrolase-L1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4.
Kim HJ; Magesh V; Lee JJ; Kim S; Knaus UG; Lee KJ
Oncotarget; 2015 Jun; 6(18):16287-303. PubMed ID: 25915537
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin C-terminal hydrolase-L1 (Uch-L1) correlates with gonadal transformation in the rice field eel.
Sun J; Shang X; Tian Y; Zhao W; He Y; Chen K; Cheng H; Zhou R
FEBS J; 2008 Jan; 275(2):242-9. PubMed ID: 18076650
[TBL] [Abstract][Full Text] [Related]
10. S-Mercuration of rat sorbitol dehydrogenase by methylmercury causes its aggregation and the release of the zinc ion from the active site.
Kanda H; Toyama T; Shinohara-Kanda A; Iwamatsu A; Shinkai Y; Kaji T; Kikushima M; Kumagai Y
Arch Toxicol; 2012 Nov; 86(11):1693-702. PubMed ID: 22752181
[TBL] [Abstract][Full Text] [Related]
11. Substrate recognition and catalysis by UCH-L1.
Luchansky SJ; Lansbury PT; Stein RL
Biochemistry; 2006 Dec; 45(49):14717-25. PubMed ID: 17144664
[TBL] [Abstract][Full Text] [Related]
12. Methylmercury, an environmental electrophile capable of activation and disruption of the Akt/CREB/Bcl-2 signal transduction pathway in SH-SY5Y cells.
Unoki T; Abiko Y; Toyama T; Uehara T; Tsuboi K; Nishida M; Kaji T; Kumagai Y
Sci Rep; 2016 Jun; 6():28944. PubMed ID: 27357941
[TBL] [Abstract][Full Text] [Related]
13. Proteomic Analysis of Hippocampus in a Mouse Model of Depression Reveals Neuroprotective Function of Ubiquitin C-terminal Hydrolase L1 (UCH-L1) via Stress-induced Cysteine Oxidative Modifications.
Choi JE; Lee JJ; Kang W; Kim HJ; Cho JH; Han PL; Lee KJ
Mol Cell Proteomics; 2018 Sep; 17(9):1803-1823. PubMed ID: 29959188
[TBL] [Abstract][Full Text] [Related]
14. N-terminal truncated UCH-L1 prevents Parkinson's disease associated damage.
Kim HJ; Kim HJ; Jeong JE; Baek JY; Jeong J; Kim S; Kim YM; Kim Y; Nam JH; Huh SH; Seo J; Jin BK; Lee KJ
PLoS One; 2014; 9(6):e99654. PubMed ID: 24959670
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of ATP-induced currents due to the activation of P2X receptors by ubiquitin carboxy-terminal hydrolase L1.
Manago Y; Kanahori Y; Shimada A; Sato A; Amano T; Sato-Sano Y; Setsuie R; Sakurai M; Aoki S; Wang YL; Osaka H; Wada K; Noda M
J Neurochem; 2005 Mar; 92(5):1061-72. PubMed ID: 15715657
[TBL] [Abstract][Full Text] [Related]
16. A new role for the neuronal ubiquitin C-terminal hydrolase-L1 (UCH-L1) in podocyte process formation and podocyte injury in human glomerulopathies.
Meyer-Schwesinger C; Meyer TN; Münster S; Klug P; Saleem M; Helmchen U; Stahl RA
J Pathol; 2009 Feb; 217(3):452-64. PubMed ID: 18985619
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin Carboxyl Terminal Hydrolase L1 Attenuates TNF-α-Mediated Vascular Smooth Muscle Cell Migration Through Suppression of NF-κB Activation.
Gao X; Wu L; Wang K; Zhou X; Duan M; Wang X; Zhang Z; Liu X
Int Heart J; 2018 Nov; 59(6):1409-1415. PubMed ID: 30305579
[TBL] [Abstract][Full Text] [Related]
18. Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1.
Koharudin LM; Liu H; Di Maio R; Kodali RB; Graham SH; Gronenborn AM
Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6835-40. PubMed ID: 20231490
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin dimers control the hydrolase activity of UCH-L3.
Setsuie R; Sakurai M; Sakaguchi Y; Wada K
Neurochem Int; 2009; 54(5-6):314-21. PubMed ID: 19154770
[TBL] [Abstract][Full Text] [Related]
20. NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression.
Wang R; Zhang M; Zhou W; Ly PT; Cai F; Song W
J Neurochem; 2011 Mar; 116(6):1160-70. PubMed ID: 21210816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
